Lee Danner & Bass Inc Merck & Co., Inc. Transaction History

Lee Danner & Bass Inc

  • $1.42 Billion
  • Q3 2024

A detailed history of Lee Danner & Bass Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lee Danner & Bass Inc holds 98,334 shares of MRK stock, worth $10.1 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
98,334
Previous 100,006 1.67%
Holding current value
$10.1 Million
Previous $12.4 Million 9.81%
% of portfolio
0.79%
Previous 0.95%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
SELL
$111.15 - $128.97 $185,842 - $215,637
-1,672 Reduced 1.67%
98,334 $11.2 Million
Q2 2024

Jul 30, 2024
BUY
$123.8 - $132.96 $195,604 - $210,076
1,580 Added 1.61%
100,006 $12.4 Million
Q4 2023

Feb 01, 2024
BUY
$100.18 - $109.02 $14,926 - $16,243
149 Added 0.15%
98,426 $10.7 Million
Q3 2023

Oct 27, 2023
SELL
$102.95 - $114.33 $118,907 - $132,051
-1,155 Reduced 1.16%
98,277 $10.1 Million
Q2 2023

Jul 31, 2023
SELL
$108.61 - $118.38 $84,824 - $92,454
-781 Reduced 0.78%
99,432 $11.5 Million
Q1 2023

May 02, 2023
SELL
$102.94 - $114.86 $271,761 - $303,230
-2,640 Reduced 2.57%
100,213 $10.7 Million
Q4 2022

Feb 01, 2023
SELL
$87.44 - $112.11 $35,588 - $45,628
-407 Reduced 0.39%
102,853 $11.4 Million
Q3 2022

Oct 31, 2022
SELL
$84.53 - $94.96 $50,126 - $56,311
-593 Reduced 0.57%
103,260 $8.89 Million
Q2 2022

Jul 25, 2022
SELL
$83.49 - $94.64 $121,644 - $137,890
-1,457 Reduced 1.38%
103,853 $9.47 Million
Q1 2022

Apr 27, 2022
SELL
$73.51 - $82.4 $40,651 - $45,567
-553 Reduced 0.52%
105,310 $8.64 Million
Q4 2021

Jan 27, 2022
SELL
$72.28 - $90.54 $201,661 - $252,606
-2,790 Reduced 2.57%
105,863 $8.11 Million
Q3 2021

Nov 01, 2021
SELL
$71.68 - $78.83 $166,010 - $182,570
-2,316 Reduced 2.09%
108,653 $8.16 Million
Q2 2021

Jul 27, 2021
BUY
$70.31 - $77.77 $13,007 - $14,387
185 Added 0.17%
110,969 $8.63 Million
Q1 2021

Apr 29, 2021
BUY
$68.86 - $81.11 $726,955 - $856,278
10,557 Added 10.53%
110,784 $8.54 Million
Q4 2020

Feb 09, 2021
SELL
$71.77 - $79.65 $35,454 - $39,347
-494 Reduced 0.49%
100,227 $8.2 Million
Q3 2020

Nov 12, 2020
SELL
$73.18 - $82.95 $388,805 - $440,713
-5,313 Reduced 5.01%
100,721 $8.36 Million
Q2 2020

Aug 10, 2020
SELL
$70.42 - $80.13 $55,279 - $62,902
-785 Reduced 0.73%
106,034 $8.2 Million
Q1 2020

May 04, 2020
BUY
$63.36 - $87.82 $637,401 - $883,469
10,060 Added 10.4%
106,819 $8.22 Million
Q4 2019

Feb 13, 2020
SELL
$77.58 - $87.54 $283,011 - $319,345
-3,648 Reduced 3.63%
96,759 $8.8 Million
Q3 2019

Oct 30, 2019
SELL
$76.08 - $82.93 $25,562 - $27,864
-336 Reduced 0.33%
100,407 $8.45 Million
Q2 2019

Jul 30, 2019
SELL
$69.84 - $81.59 $390,684 - $456,414
-5,594 Reduced 5.26%
100,743 $8.45 Million
Q1 2019

May 06, 2019
SELL
$69.58 - $79.36 $131,854 - $150,387
-1,895 Reduced 1.75%
106,337 $8.84 Million
Q4 2018

Jan 29, 2019
SELL
$65.24 - $75.71 $73,916 - $85,779
-1,133 Reduced 1.04%
108,232 $8.27 Million
Q3 2018

Nov 06, 2018
SELL
$57.69 - $67.84 $105,688 - $124,282
-1,832 Reduced 1.65%
109,365 $7.76 Million
Q2 2018

Nov 02, 2018
BUY
$50.83 - $59.72 $60,945 - $71,604
1,199 Added 1.09%
111,197 $6.75 Million
Q2 2018

Aug 06, 2018
SELL
$50.83 - $59.72 $209,622 - $246,285
-4,124 Reduced 3.61%
109,998 $7.25 Million
Q1 2018

May 02, 2018
BUY
$50.96 - $59.23 $460,678 - $535,439
9,040 Added 8.6%
114,122 $6.22 Million
Q4 2017

Feb 02, 2018
BUY
$51.62 - $61.64 $308,481 - $368,360
5,976 Added 6.03%
105,082 $5.91 Million
Q3 2017

Oct 27, 2017
BUY
$58.67 - $63.13 $5.81 Million - $6.26 Million
99,106
99,106 $6.35 Million

Others Institutions Holding MRK

# of Institutions
3,824
Shares Held
1.88B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Lee Danner & Bass Inc Portfolio

Follow Lee Danner & Bass Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Danner & Bass Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lee Danner & Bass Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email